We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Sigma-Aldrich Rubr1 Activator, Gf-15 - C
List Price
$305.28
Your Price
$305.28
Sigma-Aldrich Rubr1 Activator, Gf-15 - Calbiochem; 1ea; >=98% (Hplc) - SIAL (Additional S&H Or Hazmat Fees May Apply)
NETA PART:
SIAL-5004950001
MFG.PART:
5004950001
UNSPSC:
41115709
Manufacturer:
Sigma-Aldrich
Assay
≥98% (HPLC)
Quality Level
100
Form
solid
Manufacturer/Tradename
Calbiochem®
Storage Condition
OK to freeze
protect from light
Color
white
Solubility
DMSO: 50 mg/mL
Storage Temp.
2-8°C
General Description
A cell-permeable 2′-benzyloxy griseofulvin derivative that displays enhanced mammalian cancer-selective toxicity (IC50≤2, ≤4, ≤12, and ≥30 µM against panels of leukemia, myeloma, solid tumors, and non-malignant cell lines, respectively), but little antifungal activity, by activating spindle-assembly-checkpoint (Pos. vs. Neg. RubR1 staining of metaphase PC-3 kinetophores with or without 24 h 0.75 µM GF-15 treatment) without affecting microtubule kinetochore attachment (Neg. Mad2 staining of metaphase PC-3 kinetophores with or without GF-15). Cancer cells are reported to undergo multipolar (MP) mitosis with normal or supernumerary centrosomes (Aberrant vs. declustered, respectively) in the presence of GF-15 (%Declustered / %Aberrant MP mitotic cells among all anaphase cells = 5.6/<0.5, 10/3.9, 16/18, 28/30, respectively, in PC-3 cultures treated with 0, 0.375, 0.75, or 1.5 µM GF-15 for 24 h), resulting in subsequent apoptotic cell death. Shown to retard OPM2 myeloma- and HT29 colon cancer-derived tumor expansion in mice (by 49% and 56%, respectively at the end of 2-wk treatment; 10 i.p. dosages at 20 mg/kg/day in 2 weeks)in vivo. Based on stability data obtained with itsp-iodobenzyl analogue, GF-15 half-life is expected to be least 48 h in cultures.A cell-permeable 2′-benzyloxy griseofulvin derivative that displays enhanced mammalian cancer-selective toxicity (IC50≤2, ≤4, ≤12, and ≥30 µM against panels of leukemia, myeloma, solid tumors, and non-malignant cell lines, respectively), but little antifungal activity, by activating spindle-assembly-checkpoint without affecting microtubule kinetochore attachment. Cancer cells are reported to undergo multipolar (MP) mitosis with normal or supernumerary centrosomes in the presence of GF-15, resulting in subsequent apoptotic cell death. Shown to retard HT29 colon cancer & OPM2 myeloma tumor expansion in mice (20 mg/kg/day i.p.)in vivo. GF-15 half-life is expected to be least 48 h in cultures.Please note that the molecular weight for this compound is batch-specific due to variable water content. Please refer to the vial label or the certificate of analysis for the batch-specific molecular weight. The molecular weight provided represents the baseline molecular weight without water.
Biochem/Physiol Actions
Cell permeable: yesReversible: yesPackaging
Packaged under inert gasWarning
Toxicity: Standard Handling (A)Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.Other Notes
Raab, M.S., et al. 2012.Cancer Res. 72,5374.Ronnest, M.H., et al. 2009.J. Med. Chem. 52,3342.
Crosse, R., et al. 1964.J. Gen. Microbiol. 34,51.CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
| SKU | SIAL-5004950001 |
|---|---|
| Featured | No |
| Supplier Part Number | 5004950001 |
| UM | EA |
| UNSPSC | 41115709 |
| Manufacturer | Sigma-Aldrich |
| ProductLine | SIAL |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 9 |
| Hazardous | N |
| Energy Star | No |
| Green | No |
| ACT Ecolabel | No |
| Controlled | N |